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 In the last decade, vaccination has reduced a quarter of child deaths 
worldwide. Vaccination coverage increased, but the coverage remains low in 
the hard-to-reach population. We searched articles from Pubmed MEDLINE, 
SCOPUS, Web of Science, and Science Direct to systematically review 
interventions to improve children's vaccination coverage in hard-to-reach 
populations. The expected outcome was vaccination coverage, which 
mentioned Odds Ratio, mean difference, or difference-in-difference with a 
95% CI or p-value. Out of 102 articles identified, five articles from four 
different countries met the inclusion criteria. Four of the five studies reported 
a positive impact in increasing vaccination coverage. Interventions that 
showed good effectiveness in increasing the coverage of childhood 
immunizations were the application of mHealth given to vaccinators, 
multiple interventions involving the community, modification of 
immunization schedules during outreach activities, and immunization 
screening cards. Despite the inconsistent finding, mHealth with SMS 
reminders was the most effective intervention to increase vaccination 
coverage and relatively low-cost. More research was needed in developing a 
strategic intervention to increase vaccination coverage of children in hard-to-
reach populations. 
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1. INTRODUCTION  
The global vaccine action plan (GVAP) central vision is a world free from vaccine-preventable 
diseases [1]. Since 2010, immunization has contributed significantly to reducing a quarter of the number of 
child deaths due to vaccine-preventable disease worldwide, from 52 to 39 deaths per 1,000 live births 
[2]. Vaccinations prevented 10 million deaths between 2010 and 2015, and many more since 2000 [3]. 
Vaccination coverage has also reportedly increased. The second dose of measles-containing-vaccine (MCV) 
coverage increased from 42% in 2010 to 69% in 2018. There are 95 countries with DPT3 coverage of 90% in 
each region, exceeding the GVAP target of 80% in every district [4]. However, there still are disparities. In 
some regions with conflicts and weak health systems, remote areas, or urban slums, childhood vaccination 
coverage remains low [5]. 
Low vaccination coverage levels prevent herd immunity to build, hence vulnerable to an outbreak. 
Two doses of the measles vaccine with a minimum coverage of 97% are required to obtain herd immunity 
against the measles virus in Europe [6]. Although national coverage of measles vaccine over World Health 
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Organization (WHO) standards, if the clustering of non-vaccination children exists, outbreaks can occur 
because of the decreasing local immunity threshold [7], [8]. There are several causes for the low coverage of 
immunization: marginalized economic and social status, poor urban areas, remote and rural areas [2]. This 
condition is related to access and reachability. Hard-to-reach populations for vaccination are groups of people 
who experience vaccination barriers due to distance and geographic location, non-permanent residence, 
unavailability of health services, inadequate immunization systems, conflict, and war [9]. In Middle East, 
conflict-stricken populations are low in vaccination coverage and treatable disease, resulting in cholera and 
polio outbreaks [10]. Not only vaccination problems but also maternal health such as birth preparedness and 
readiness level are also lower in hard-to-reach areas [11]. All this evidence suggests that addressing hard-to-
reach populations as a target intervention to improve maternal and child health, especially immunization, is 
crucial in achieving 14 of the 17 sustainable development goals [12].  
Special efforts are needed to conduct vaccination in hard-to-reach and areas. This kind of 
intervention is usually high-cost [13], with non-vaccine cost (program management, human resources, social 
mobilization, surveillance, capacity building) was higher than vaccine cost [14]. However, the finding from a 
previous modeling study in Kenya showed that unvaccinated children with measles vaccine from 2016 to 
2020 resulted in a loss of $9.5 million in medical costs and productivity, and conducting vaccination in 
geography hard-to-reach area are highly cost-effective [15]. A modeled vaccination strategy in the 
Democratic Republic of Congo also showed that delivering a second dose of MCV would save more than the 
US $199 million [16]. This figure also indicates the importance of increasing vaccination coverage in hard-
to-reach populations.  
A systematic review on delivering prevention of infectious disease in women and children in 
conflict hard-to-reach settings had been conducted previously [17], but not evaluating the coverage increased 
of interventions implemented. There has been no systematic review of which strategies effectively increase 
childhood immunization coverage in hard-to-reach populations. Therefore, this systematic review was 
prepared to evaluate interventions to increase child vaccination coverage in hard-to-reach populations. 
 
 
2. RESEARCH METHOD 
We conducted a systematic review of interventions to increase child vaccination coverage in hard-
to-reach populations. We used the PRISMA checklist as a writing guideline to ensure all steps are carried out 
correctly [18]. Two reviewers were responsible for reviewing titles, abstracts, and full texts for inclusions. 
Population, intervention, comparison, outcome (PICO) framework was used to clarify the eligibility criteria 
for inclusion and exclusion of relevant articles [19], summarized in Table 1. 
 
 
Table 1. PICO for inclusion and exclusion criteria 
 Include Exclude 
Population Studies on pregnant women, children under five years 
old, health care staffs from hard-to-reach settings 
Studies on school-age children, adult, elderly, and 
animals 
Interventions Studies evaluated interventions to scaling up 
childhood vaccination coverage during routine 
immunization, campaign, or new program 
implementation.  
Studies which interventions to improve childhood 
vaccination coverage was conducted due to response 
for disease outbreak. 
Comparison Standard health care service/ usual practice, or other 
interventions to improve childhood vaccination 
coverage; conditions before implementing 
interventions 
No comparison of different actions to improve 
vaccination coverage 
Outcome The outcome of interest was childhood vaccination 
coverage before and after an intervention. The 
expected outcome measure was the Odds Ratio, mean 
difference, or difference in difference (DID) with a 
95% Confidence Interval or p-value. 
The outcome of interest was the proportion of 
childhood vaccination coverage in descriptive 
statistics only, without further data analysis.  
 
 
We only included studies in English. Study designs included as inclusion criteria were trials, 
observational analytic studies, and before-after studies. Other exclusion criteria were studies with the pure 
qualitative design, modeling, review, editorial, opinion, and commentary. Inaccessible studies were also an 
exclusion criterion. To minimize the risk of bias, gray literature and studies that have not been peer-reviewed 
were not included.  
In conducting our search, we used a combination of five sets of keywords: i) Child, infant, 
pediatrics; ii) hard-to-reach communities, hard-to-reach population, hard-to-reach area, remote area, difficult 
area; ii) vaccination, immunization; iv) uptake, coverage, rates, outcomes; v) strategies, programs, interventions. 
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The search was conducted on four journal databases, Pubmed MEDLINE, SCOPUS, Web of 
Science, and Science Direct. We searched for all studies published since 2012, one year after the initiation of 
GVAP, hoping that the selected studies will reflect the follow-up of the launch of GVAP in 2011. All articles 
obtained from the database search were imported into the Zotero database manager to identify duplicate 
journals, review titles, and abstracts. Data extraction was carried out on selected articles for full-text review 
by two reviewers independently. We use Microsoft Excel to tabulate extracted data. We included authors, 
year of publication, study purpose, setting, design, subjects/ participants, interventions, outcomes, and 
limitations of the study.  
To minimize the risk of bias, we used several tools to assess risk of bias specific to each study 
design. We used ROBINS-I for non-randomized studies for interventions [20] and RoB 2 for randomized 
trials [21], with additional considerations for cluster-randomized trials [22]. For uniformity in judging the 
overall risk of bias, we classified serious and critical risk of bias in ROBINS-I and high risk of bias in RoB 2 
as "high risk". Otherwise, we categorized it as "low risk". In the event of disagreement, we resolved any 
discrepancy by discussion and consensus. In this systematic review, each study's level of evidence was 
assessed using the National Health and Medical Research Council (NHMRC) criteria [23].  
 
 
3.  RESULTS AND DISCUSSION 
3.1.  Results 
We conducted an article search on 13-20 December 2020 and identified 102 articles from 
four databases. After removing duplication, there were 58 articles to screen for titles and abstracts. After 
eliminating irrelevant articles, we found 14 articles to be thoroughly reviewed and leaving three articles for 





Figure 1. PRISMA diagram 
 
 
The five included studies came from four different countries: Bangladesh (n=2), Afghanistan (n=1), 
Pakistan (n=1), and India (n=1). Two articles had a cluster-randomized trial design, two quasi-experimental, 
and one cross-sectional before-after study. The intervention duration varied with a minimum of 12 months 
and a maximum of four years as shown in Table 2. 
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520 children in baseline and 520 
children in end line from rural 
interventions area 
518 children in baseline and 520 
children in end line from urban 
interventions area 




MHealth mTika android and web-based 
application which functions are: 
(1) Registration of pregnant women 
(2) Receive short message service (SMS) 
notifications of baby birth sent by mothers 
(3) Sending automatic SMS immunization 
reminders for mothers 
(4) Vaccination reminders for health workers 
(5) Monitoring of immunization programs by 
health supervisors 
Comparator: 













338,798 pregnant women  
1,693,872 children under five years 
Intervention: 
Mobile health teams (MHTs) that focus on 
maternal and child health (MCH) were 
implemented in the intervention areas. 
MHT consists of midwife nurses and 
vaccination officers. MHT visits remote and 
conflict-affected villages for 1 to 2 days every 
two months for outreach. 
MHT-MCH services are 
(1) Vaccination outreach 
(2) Mobile clinics for adults 
(3) Scheduled health services for mothers and 
children under five years 
    Comparator: 
Standard ministry of health services include 
vaccination outreach and mobile health 














1,440 mothers and children in the 
baseline survey and 1,441 mothers 
and children in the end-line survey 
in Sunamgonj district 
1,440 mothers and children in the 
baseline survey and 1. mothers and 
children in the end-line survey in 
Rangamati district 
Group A 
(1) Refresher training for immunization 
officers on valid dose and adverse events. 
(2) Re-design vaccine supply system  
(3) Modification of immunization schedule 
(4) Community support groups  
Group B 
(1) Refresher training for immunization 
officers on valid dose and adverse events. 
(2) Re-design vaccine supply system 












28,760 children under five in arm A 
30,098 children under five in arm B 
29,126 children under five in arm C 
End-line 
23.334 children under five in arm A 
26,110 children under five in arm B  
25,745 children under five in arm C 
Arm A 
Routine immunization package with the 
addition of oral polio vaccine (OPV) 
supplementary immunization activities 
Arm B: 
(1) Arm A plus 
(2) Community and mobilization outreach 
(3) Improved communications 
(4) Provision of maternal and child health 
services through low-cost health camps 
Arm C: 
(1) Arm B plus 
(2) Providing additional inactivated polio 














1,571 mothers with children aged 1-
4 months  
1,757 mothers with children aged 6-
9 months 
Control: 
1,452 mothers with children aged 1-
4 months  
1,713 mothers with children aged 6-
9 months 
Intervention: 
The use of ImTeCHO mHealth application by 
assisted social health activists (ASHAs)  
Comparator: 
Standard health care of ASHAs 
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Three studies evaluated single interventions, i.e., service innovation using mHealth application [24], 
[28], and mobile outreach services under challenging locations [25]. Two other studies evaluated multiple 
interventions consisting of refresher training, modification immunization schedule, community engagement, 
immunization screening checklist [26], and community outreach to provide maternal and child health service 
[27]. Four of the five studies reported a positive impact in increasing vaccination coverage [24]-[27], and one 
study did not show superiority over than standard package [28]. Interventions that show good effectiveness in 
increasing the coverage of childhood immunizations are the application of mHealth, given to vaccinators 
with SMS reminders (OR 3.6, 95% CI 1.5 to 8.9, p<0.001). Multiple interventions involving the community, 
modification of immunization schedules during outreach activities, and immunization screening cards also 
effectively increased coverage (OR 3.02, 95% CI 2.58 to 3.54, p<0.01). Only one study using multiple 
interventions reached the WHO target for immunization coverage >80% [26]. Changes in vaccination 
coverage after intervention can be seen in Table 3 (see in appendix). 
Four of five studies had a low to moderate risk of bias due to randomization. One study had critical 
risk because it was not randomized, and no clear baseline for each group [25]. Deviations from intended 
interventions were observed in two studies [24], [26], which reported no standardized interventions delivered 
because of the context of intervention. All five studies had some concerns in measuring the outcome; 
caregiver recall was used to obtain vaccination status. Although this method had quality concerns [29], this 
method was still acceptable, especially in lower and middle-income countries, and encouraged to be used in 
combination with vaccination cards and health care facilities documentation [30]. Due to the design of quasi-
experimental, repeated cross-sectional studies, there was unclear evidence of missing outcome data in three 
studies [24]-[26]. Based on our pre-existing criteria assessment, four studies were categorized as low [24], 
[26]-[28], and one study categorized as high risk of bias [25]. 
 
3.2.  Discussion  
This systematic review aimed to identify appropriate interventions to increase child vaccination 
coverage in hard-to-reach populations. The five selected studies provided an overview of potential interventions 
to increase child vaccination coverage in hard-to-reach populations. The limited number of studies that raised 
this issue showed that child immunization in hard-to-reach populations had not been given much attention, even 
though child vaccination coverage is still one of the world's global health problems [31].  
 
3.2.1. Post-intervention vaccination coverage 
One of the essential meanings of vaccination coverage is finding out community access to healthcare 
[32]. Measles coverage is an important indicator of achieving sustainable development goal (SDG) 3, 
―ensure healthy lives and promoting well-being for all at all ages‖. The high rate of measles transmission 
requires at least 95% of measles1 and measles2 vaccines coverage to prevent transmission [33]. Our findings 
in this study indicate that despite a significant increase in coverage after interventions were reached, none of 
the studies achieved a minimum coverage of measles immunization of 95% as shown in Table 3 (see in 
appendix). Other findings in this study also show that only one study achieved the target of at least 80% of all 
childhood immunization coverage in every district [4]. The low post-intervention coverage indicates 
that difficult-to-reach populations were still a significant challenge in the immunization program. Remote and 
conflict-prone areas have worse maternal and child health than other areas due to the difficulty of providing 
prevention and treatment services [34]. More than just temporary interventions were needed. Interventions 
that were sustainable and applied to a broader location were expected to increase vaccination coverage with 
long-term impacts. Communication about the importance of vaccination and vaccine safety should be 
improved, and a strategy for tracking drop-out cases should also be a priority [35]. 
 
3.2.2. Intervention strategies to increase vaccination coverage 
Of the five articles selected for this study, interventions that seem to give rise significantly compared 
to the coverage number of baseline conditions is the application of mHealth mTika and the multiple 
interventions in Bangladesh, with each having a value of OR more than three [24], [26]. One study with 
multiple interventions: community mobilization, improved communication, and health camps increased 3 to 
15% over baseline despite requiring higher costs [27]. The intervention with the mobile health team in the 
Afghanistan study did not record baseline values and therefore could not be compared [25]. The 
mHealth intervention with ImTeCHO did not show a significant increase in coverage [36]. 
mTika mHealth application showed the largest size of the impact of increasing coverage in the 
intervention area with OR 3.6. This strategy worked well in Bangladesh [24] but not India [28]. We estimate 
this is due to differences in application users. In Bangladesh, the mTika application was given directly to 
vaccine officers to carry out direct tracking [24]. Furthermore, periodic automatic SMS reminders to mothers 
before the immunization schedule made the mTika application more effective in increasing vaccination 
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coverage than ImTeCHO. In India, ImTeCHO application was no superior to standard immunization 
services. A previous study identified gaps in the performance of ASHAs in mobilizing mothers and children 
for immunization [36]. However, giving mobile phones to ASHAs did not answer this problem. This 
inconsistent benefit was also reported in a previous systematic review conducted by Cock et al. [37] 
Furthermore, Oliver-Williams et al. [38] reported that only a little evidence supports mobile apps' use to 
increase vaccination coverage. Therefore, despite 4.5 billion people have mobile phones and SMS technology 
has proven to improve maternal and child health services in developing countries [39], the use of mobile apps 
to increase vaccination coverage in hard-to-reach populations still needs further research. 
Travel to health services affects infant vaccination coverage. Penta3 vaccination coverage was lower in 
children who live with travel time to health services >60 minutes than <30 minutes [40]. In this case, mobile 
health teams effectively reduced travel time to health care centers. A mobile clinic was a unit that aims to 
provide medical services, diagnosis, and treatment for patients in remote areas [41]. Although common 
obstacles to this type of intervention are financial problems, human resources, and logistical limitations [42], 
this service is considered cost-effective compared to build a permanent health unit in remote and hard-to-reach 
areas [41]. Therefore, to have sustainability in implementing this type of service, good planning of various 
programs and funding must be done simultaneously by stakeholders. 
A good schedule of team visits also enhanced mobile health teams' effectiveness. Studies in Nigeria 
showed that immunization utilization was affected by health care problems. Lack of services, lack of health 
personnel, and vaccines' absence on a predetermined schedule lead to low immunization utilization [43]. 
Modifications to the immunization schedule such as those carried out in Bangladesh were a strategic way of 
dealing with this. Changing the outreach schedule by mobile immunization from one day monthly to every 
two months for two days provides more opportunities for every child to access immunizations. More children 
can be served by staying longer because the vaccination service is not limited to particular hours. Parents 
who work in the morning can bring their child in the afternoon or the following day. For officers, this 
schedule modification also saves expenses because they do not need to come every month. This schedule 
change is also in accordance with the WHO routine immunization schedule recommendations, which allows 
intervals between DPT vaccines of four and eight weeks [44].  
One of the things that are very crucial in immunization services besides coverage is the quality of 
vaccines. The most potential of the vaccine can be achieved if the cold chain system is well implemented. This 
includes vaccine storage and transportation from factories to health facilities where vaccinations are carried out 
and outreach locations. Various methods were developed to improve the vaccine delivery system, namely 
preventing vaccine freezing using cold water instead of ice, temperature monitoring systems in vials, and better 
cold chain related control and regulatory systems [45]. One of the efforts made to maintain the cold chain 
system's integrity in hard-to-reach areas is re-designing the vaccine delivery system, as reported by Uddin et al. 
in Bangladesh. Vaccines were no longer sent from an area's capital but rather sent from adjacent cities [26]. The 
goal was to cut the mileage and reduce travel time to reduce vaccine damage due to the long trip. This method is 
good enough but requires more coordination with other districts as it will also change their cold chain system. 
This needed additional work by officials from other districts to get the vaccine to a certain point, which requires 
additional costs and therefore should be included in the evaluation component. 
In Bangladesh, the establishment of a community support group consisting of immunization hosts, 
mothers with fully immunized children, village defense members, male and female students, representatives 
of non-profit organizations, traditional birth attendants, and traditional healers increased vaccination 
coverage [26]. A study from Pakistan also reported increased vaccination coverage after training lady health 
workers and traditional birth attendants as community mobilizers [46]. Habib et al. reported that community 
communication campaigns have also effectively increased oral polio immunization coverage [27]. However, 
this kind of intervention is usually hindered by funding constraints, inadequate infrastructure and equipment, 
community stakeholders' attitudes, and political factors [47]. 
Uddin et al. reported positive outcomes from multiple interventions to improve the health system 
[26]. Refresher training for Public Health staff, re-design vaccine supply system, and providing immunization 
screening checklist increased complete immunization coverage 26 to 29%. The combination of this 
intervention with community engagement increased the coverage even more remarkable, with OR 3.02, 
compared to baseline. These interventions were worldwide accepted and recommended to improve 
vaccination coverage. Refresher training has been routinely recommended to strengthen the immunization 
program. It is recommended by WHO [48], and UNICEF recommended rapid card check for immunization 
to evaluate immunization program at the household level [49]. Thus, the combination of these interventions 
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3.2.3. Cost-Effectiveness of Interventions 
Vaccination was known as a lifetime investment. Even in the lower and middle-income countries, 
vaccination contributed as protection against poverty [50]. Nevertheless, the cost is high in hard-to-reach 
geography. Of the five studies, mHealth mTika intervention was the most cost-effective because only using 
SMS reminders to obtain a significant increase in vaccination coverage. Mobile health teams and health 
camps that take the form of outreach activities, whether conducted in Afghanistan or Pakistan, are considered 
to be at a high-cost [25], [27]. Habib et al. noted that the cost of adding a low-cost health camp was not low. 
Apart from the additional costs, additional human resources, training, and supervision were added to standard 
immunization services. Therefore, these interventions cannot replace existing standard immunization 
services, although they can increase vaccination coverage [27]. The thing that needs to be considered in high-
cost activities is the sustainability of these activities related to funding. If the funds needed are not available, 
the program's continuity is threatened so that there is concern that coverage will decline.  
Uddin et al. wrote that multiple interventions at the study sites were provided without additional 
costs because they were implementing their intervention by using existing resources [26]. This kind of 
intervention needs to do with caution because the additional work without additional appreciation could 
jeopardize the system's sustainability. A study in Myanmar of health workers and cadres in hard-to-reach 
areas showed that government incentives, transportation support, training, and residents' acceptance affected 
their work productivity [51]. 
A study reported that ImTeCHO was cost-effective in improving India's infant mortality [52]. 
However, there was no record of its cost-effectiveness in overall maternal and child health programs, 
especially in increasing vaccination coverage. Furthermore, considering that the costs incurred with this 
system not only the purchase of equipment but also credit and the cost of service, and replacement when lost 
or stolen, the use of ImTeCHO was ineffective and costly in improving vaccination coverage.  
 
3.2.4. Limitations 
This systematic review's major limitation was the small number of studies identified. Differences in 
design between studies make it difficult to conclude the size of the impact of more controlled interventions. 
There were only two randomized controlled trial (RCT) studies with a low risk of bias, two quasi-
experimental studies with a low risk of bias, and one cross-sectional study with a high risk of bias in this 
systematic review. Therefore, conclusions regarding the intervention's effectiveness are varying. Considering 
all these limitations, the level of evidence for interventions to increase vaccination coverage for children in 
hard-to-reach populations is therefore low (NHMRC level of evidence III-3). 
 
 
4.  CONCLUSION 
To our knowledge, this is the first article that systematically reviewed interventions to improve 
vaccination coverage in hard-to-reach populations. Our systematic review shows that the mHealth application 
shows high effectiveness if appropriately addressed, although it needs further research. Multiple interventions 
involving existing health systems are highly effective and low-cost. Mobilization of health teams to hard-to-
reach areas can increase vaccination coverage but requires high costs and additional resources to carry out 
these activities. Costs can be reduced if the intervention is integrated with the existing health system so that 
there is no need to bring in additional human resources. However, we recommend that additional incentives 
be provided to health workers and community groups who conduct outreach to motivate them to carry out 
their duties. Given the costs incurred, better program planning and targeting a broader program are needed to 
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Children aged >298 days received complete BCG + Penta3 + MR vaccination Low 
/III-2 Intervention (rural)  
58.9 76.8 
(+)18.8 (5.7 to 
31.9) 
p<0.001 
DID (+)29.5 OR 3.6 (1.5 to 8.9) 
p<0.001  
Control (rural) 
There was an increase in coverage in the intervention 
group and decreased coverage in the control group, which 







Children aged >298 days never vaccinated.  
 Intervention (rural)  
9.2 1.4 
(-)7.7 (-13.4 to 
-2.0) 
p<0.001 
DID (-)9.9 OR 0.04 (0 to 0.09) 
p<0.001  
There was a statistically significant reduction in the 
coverage of children who never 
 
Control (rural)  
Received the vaccine in the intervention areas. 
 
0.8 3.0 
(+)2.2 (-2.2 to 
6.6)  
[25] 
The proportion of infants receiving Penta3 vaccine 
High 
/III-3 
Intervention   Mean difference 7.55 (-4.2 to 19.3) 
 
No data 76.4 SD 28.7 p 0.20 
Control   There was no statistically significant difference between 
the intervention and control groups for the proportion of 
infants receiving the Penta3 vaccine. 
No data 62.4 SD 33.9 
The proportion of infants receiving measles vaccine-1  
 Intervention  Mean difference 12.78 (2.08 to 23.48) 
p 0.02 
There was a statistically significant difference in the mean 
proportion of infants receiving measles1 vaccine between 
the intervention and control groups 
 
 No data 73.8 SD 26.6  
 Control    
 No data 57.3 SD 30.5 
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Vaccination coverage for children aged 12-23 months  
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Group B compared to group A: 
OR 2.09 (1.73 to 2.53) 
p <0.01 
 
End-line versus baseline: 
OR 3.02 (2.58 to 3.54) 
p <0.01 
 
Hill versus haor: 
OR 1.54 (1.30 to 1.82) 
p <0.01 
 
The increase in vaccination coverage for children aged 12-
23 was statistically significant in the intervention groups 
A and B, with groups B and hill having a higher 
probability of experiencing an increase in coverage. 
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Complete immunization according to age 
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Increased proportion of complete immunizations  
Arm B versus arm A 
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Arm C versus arm A 
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Arm B   9.5 (6.9 to 12.0) 
p<0.0001 
There was a significant increase in the proportion of 
children who received complete immunization after the 
intervention in arm B and C compared to arm A (control) 
22 (19 to 24) 
32 (29 to 
35) 
10 
Arm C   
22 (20 to 24) 
34 (31 to 
37) 
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Immunization left out 
Arm A  
42 (39 to 46) 
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42 (38 to 46) 
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31) 
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Arm C   
42 (38 to 46) 
27 (24 to 
30) 
15 
The proportion of mean vaccine dose 
received during the scheduled supplemental 
immunization 
Intervention B effect 9% (7 to 11) 
Intervention C effect 11% (9 to 13)  
Arm A   
p<0.0001 
There was an increase in the mean proportion of vaccines 
received as the addition of interventions (B and C) was 
statistically significant. 
 
 39 (37 to 42) 
43 (40 to 
45) 
4 
 Arm B   
 39 (36 to 41) 
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56) 
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[28] Percentage of Penta3 vaccine acceptance in 
infants aged 6-9 months 
Intervention: 73.0 (70.3 to 75.8) 
Control: 73.6 (70.9 to 76.4) 
Adjusted effect size: 1.1  





There was no significant difference between the 
intervention and control groups receiving the Penta3 dose 
for infants aged 6-9 months. 
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